One explanation of why we did not observe an increase of α-synuclein aggregate concentrations in stool of PD patients or a correlation with age or disease duration may be the recently proposed “brain-first” and “body-first” PD subtypes with different affection of the ENS, making it harder to observe a difference to healthy controls57–59. This evidence concerns the gene SNCA and Parkinson disease.